PT3587445T - Um marcador de oligomerização compreendendo uma região fc de imunoglobulina e um domínio poli-his - Google Patents

Um marcador de oligomerização compreendendo uma região fc de imunoglobulina e um domínio poli-his

Info

Publication number
PT3587445T
PT3587445T PT191840180T PT19184018T PT3587445T PT 3587445 T PT3587445 T PT 3587445T PT 191840180 T PT191840180 T PT 191840180T PT 19184018 T PT19184018 T PT 19184018T PT 3587445 T PT3587445 T PT 3587445T
Authority
PT
Portugal
Prior art keywords
immunoglobulin
region
oligomerization tag
polyhis domain
polyhis
Prior art date
Application number
PT191840180T
Other languages
English (en)
Original Assignee
Grifols Diagnostic Solutions Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grifols Diagnostic Solutions Inc filed Critical Grifols Diagnostic Solutions Inc
Publication of PT3587445T publication Critical patent/PT3587445T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596Molecules with a "CD"-designation not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/24Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a MBP (maltose binding protein)-tag
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/30Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/50Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT191840180T 2017-08-10 2018-06-01 Um marcador de oligomerização compreendendo uma região fc de imunoglobulina e um domínio poli-his PT3587445T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762543788P 2017-08-10 2017-08-10

Publications (1)

Publication Number Publication Date
PT3587445T true PT3587445T (pt) 2024-03-14

Family

ID=62846219

Family Applications (1)

Application Number Title Priority Date Filing Date
PT191840180T PT3587445T (pt) 2017-08-10 2018-06-01 Um marcador de oligomerização compreendendo uma região fc de imunoglobulina e um domínio poli-his

Country Status (17)

Country Link
US (3) US11708418B2 (pt)
EP (3) EP4296680A3 (pt)
JP (3) JP6833851B2 (pt)
KR (2) KR102631281B1 (pt)
CN (2) CN117820498A (pt)
AR (1) AR112357A1 (pt)
AU (2) AU2018313028B2 (pt)
BR (1) BR112020002636A2 (pt)
CA (1) CA3070789A1 (pt)
EA (1) EA202090265A1 (pt)
ES (1) ES2911243T3 (pt)
MX (1) MX2020001489A (pt)
PL (1) PL3587445T3 (pt)
PT (1) PT3587445T (pt)
TW (1) TW201910349A (pt)
UY (1) UY37757A (pt)
WO (1) WO2019030581A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202000692A (zh) * 2018-02-20 2020-01-01 美商格里佛診斷方法股份有限公司 包含GpIbα的多肽和組合物、編碼該多肽的核酸及包含該多肽或該核酸的細胞
CN112048019B (zh) * 2019-06-06 2023-05-09 鲁南制药集团股份有限公司 抗人cd47单克隆抗体
WO2022056193A1 (en) * 2020-09-10 2022-03-17 Casi Pharmaceuticals, Inc. Methods of blood screening
CN112285361B (zh) * 2020-09-27 2023-12-05 中国人民解放军空军军医大学 排除抗-cd38单克隆抗体药物对抗人球蛋白检测干扰的试剂
CN114917413B (zh) * 2022-06-14 2023-04-28 健诺维(成都)生物科技有限公司 一种负载重组多肽的羊膜及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994511A (en) * 1997-07-02 1999-11-30 Genentech, Inc. Anti-IgE antibodies and methods of improving polypeptides
US6506551B1 (en) * 1999-10-08 2003-01-14 North Shore - Long Island Jewish Research Institute CD38 as a prognostic indicator in B cell chronic lymphocytic leukemia
US20020102250A1 (en) * 2000-06-30 2002-08-01 Deibel Martin R. Recombinant S. aureus peptide deformylase
MXPA06008700A (es) * 2004-02-06 2007-01-19 Morphosys Ag Anticuerpos anti-cd38 humanos y usos para los mismos.
JP5476122B2 (ja) * 2006-09-26 2014-04-23 ゲンマブ エー/エス Cd38発現腫瘍の併用処置法
EP1914242A1 (en) * 2006-10-19 2008-04-23 Sanofi-Aventis Novel anti-CD38 antibodies for the treatment of cancer
CA2738566C (en) 2008-10-01 2024-04-30 Micromet Ag Bispecific single chain antibodies with specificity for high molecular weight target antigens
US20120034228A1 (en) * 2008-10-01 2012-02-09 Micromet Ag CROSS-SPECIES-SPECIFIC PSCAxCD3, CD19xCD3, C-METxCD3, ENDOSIALINxCD3, EPCAMxCD3, IGF-1RxCD3 OR FAPALPHAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
WO2010083253A2 (en) * 2009-01-14 2010-07-22 Viral Logic Systems Technology Corp. Cd47 related compositions and methods for treating immunological diseases and disorders
ES2586579T3 (es) * 2010-02-19 2016-10-17 Xencor, Inc. Nuevas inmunoadhesinas de CTLA4-IG
US20130029358A1 (en) * 2010-04-01 2013-01-31 Ludwig Institute For Cancer Research Ltd. Immunodominant mhc dr52b restricted ny-eso-1 epitopes, mhc class ii monomers and multimers, and uses thereof
EP2530089A1 (en) * 2011-06-03 2012-12-05 Bayer Pharma Aktiengesellschaft Neutralising prolactin receptor antibody Mat3 and its therapeutical use
US9599606B2 (en) * 2014-06-10 2017-03-21 The Board Of Regents Of The University Of Texas System ADP-ribose detection reagents
MA40894A (fr) 2014-11-04 2017-09-12 Glenmark Pharmaceuticals Sa Immunoglobulines hétéro-dimères reciblant des lymphocytes t cd3/cd38 et leurs procédés de production
US10806787B2 (en) * 2015-02-16 2020-10-20 Pharma Foods International Co., Ltd. Anticancer agents or antimetastatic agents using FSTL1 and combination drug thereof
US9850288B2 (en) * 2015-03-16 2017-12-26 The Catholic University Of America Method of purifying authentic trimeric HIV-1 envelope glycoproteins comprising a long linker and tag
HUE048111T2 (hu) * 2015-03-23 2020-05-28 Bayer Pharma AG Anti-CEACAM6 ellenanyagok és alkalmazásuk
MA43219A (fr) * 2015-11-10 2018-09-19 Univ Medical Center Hamburg Eppendorf Polypeptides de liaison d'antigène dirigés contre cd38

Also Published As

Publication number Publication date
JP7289328B2 (ja) 2023-06-09
KR102631281B1 (ko) 2024-01-30
TW201910349A (zh) 2019-03-16
CN117820498A (zh) 2024-04-05
US20240092929A1 (en) 2024-03-21
CA3070789A1 (en) 2019-02-14
EP3587445B1 (en) 2023-12-13
BR112020002636A2 (pt) 2020-07-28
EP3464343A1 (en) 2019-04-10
EA202090265A1 (ru) 2020-06-05
PL3587445T3 (pl) 2024-04-29
ES2911243T3 (es) 2022-05-18
KR20200035194A (ko) 2020-04-02
AR112357A1 (es) 2019-10-23
AU2018313028A1 (en) 2020-02-20
AU2023204121A1 (en) 2023-07-20
JP2021088567A (ja) 2021-06-10
EP4296680A2 (en) 2023-12-27
CN109790210A (zh) 2019-05-21
CN109790210B (zh) 2024-03-26
KR20240015159A (ko) 2024-02-02
AU2018313028B2 (en) 2023-05-25
MX2020001489A (es) 2020-03-20
EP3587445A1 (en) 2020-01-01
US11708418B2 (en) 2023-07-25
US20210198376A1 (en) 2021-07-01
EP4296680A3 (en) 2024-03-20
WO2019030581A1 (en) 2019-02-14
JP6833851B2 (ja) 2021-02-24
EP3464343B1 (en) 2022-03-23
UY37757A (es) 2018-11-30
JP2023041802A (ja) 2023-03-24
US20240132616A1 (en) 2024-04-25
JP2019527533A (ja) 2019-10-03

Similar Documents

Publication Publication Date Title
PL3587445T3 (pl) ZNACZNIK OLIGOMERYZACJI ZAWIERAJĄCY REGION Fc IMMUNOGLOBULINY I DOMENĘ POLYHIS
IL264011A (en) Antibodies against tim3 and their uses
DK3638598T3 (da) Beholder og lukkesystem
EP3655906A4 (en) SECURE LABELS
GB201704508D0 (en) Contextual task shortcuts
EP3682412A4 (en) INTELLIGENCE OF INDUSTRIAL GOODS
EP3677055A4 (en) MOBILE LABEL DETECTION AND LOCATION CALCULATION
DK3720906T3 (da) Flaskelukningsenhed omfattende en polyethylensammensætning
GB202010666D0 (en) Facilitation of domain and client-specific application program interface recommendations
EP3660535A4 (en) LABEL AND DEVICE AND METHOD FOR DETERMINING THE LABEL POSITION
ZA201906924B (en) Label application systems
DK3625754T3 (da) Tag-sporing af beholdere
EP3444899A4 (en) RFID TAG
EP3719035A4 (en) POLYPEPTIDE INCLUDING AN ANTIGEN BINDING DOMAIN AND A TRANSPORT SECTION
GB202010629D0 (en) Facilitation of domain and client-specific application program interface recommendations
SG11202000775SA (en) Fusion tags for recombinant protein expression
EP3577410A4 (en) PERMANENT SYSTEM MANAGEMENT LABEL
GB201911206D0 (en) Systems, devices and methods for label-free shipping
EP3889838A4 (en) RFID TAG
GB201714372D0 (en) Macrocyclisation tags
EP3444756A4 (en) RFID TAG AND RFID SYSTEM
SG11202105365RA (en) Modified fc region
ES1205164Y (es) Conjunto de etiqueta nfc y protector para dicha etiqueta
GB202016672D0 (en) Bottle tag
SG11202003114UA (en) Transthyretin immunoglobulin fusions